Literature DB >> 21497631

Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.

Wendy P J den Elzen1, Ann C M T Vossen, Herman J M Cools, Rudi G J Westendorp, Aloys C M Kroes, Jacobijn Gussekloo.   

Abstract

Ample evidence suggests that infection with cytomegalovirus (CMV) leads to accelerated aging of the immune system and may contribute to poor responsiveness to influenza vaccination in older persons. The objective of this study was to investigate whether CMV infection, acquired earlier in life, affects the response to influenza vaccination in a randomized controlled trial among older persons in long-term care facilities. During the 1997-1998 influenza season, 731 residents (median age 83 [interquartile range 78-88], 75.4% female) in 14 long-term care facilities in the Netherlands were randomly assigned to receive 15 or 30 μg of inactivated influenza vaccine, followed by a 15 μg booster vaccine or a placebo vaccine at day 84. Blood samples were collected at day 0, day 25, day 84 and day 109. Seroresponses to influenza vaccination were measured by hemagglutination-inhibition tests to the A/H3N2 strain at all time points. Subsequently, baseline levels of IgG anti-CMV antibodies were measured using an automated chemiluminescent microparticle immunoassay. Participants with CMV antibody level≥6 AU/mL were considered to harbor CMV infection. At baseline, no differences in pre-vaccination geometric mean antibody titers (GMT) were observed between participants with (n=571, 78.1%) or without CMV infection (n=160, 21.9%). During follow-up, participants with and without CMV infection had similar responses to influenza vaccination as measured with changes in GMT (linear mixed model, adjusted for gender, age, pre-vaccination GMT and vaccination strategy, p=0.46). Analogously, no association was found between CMV infection and a more than 4-fold increase in antibody titer (Generalized Estimating Equations, adjusted OR 1.14 [95%CI 0.80;1.64]) or an antibody titer≥40 (adjusted OR 1.24 [95%CI 0.86;1.80]). In conclusion, CMV infection did not explain poor responsiveness to influenza vaccination in residents of long-term care facilities.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497631     DOI: 10.1016/j.vaccine.2011.03.086

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

3.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

4.  Association of CMV, HBV, or HCV co-infection with vaccine response in adults with well-controlled HIV infection.

Authors:  S B Troy; A E B Rossheim; J Siik; T D Cunningham; J A Kerry
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

5.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

6.  Subclinical Cytomegalovirus Infection Is Associated with Altered Host Immunity, Gut Microbiota, and Vaccine Responses.

Authors:  Clarissa Santos Rocha; Lauren A Hirao; Mariana G Weber; Gema Méndez-Lagares; W L William Chang; Guochun Jiang; Jesse D Deere; Ellen E Sparger; Jeffrey Roberts; Peter A Barry; Dennis J Hartigan-O'Connor; Satya Dandekar
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

7.  Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults.

Authors:  Anna Wald; Stacy Selke; Amalia Magaret; Michael Boeckh
Journal:  J Med Virol       Date:  2013-09       Impact factor: 2.327

Review 8.  'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function.

Authors:  Paul Moss
Journal:  Med Microbiol Immunol       Date:  2019-05-03       Impact factor: 3.402

9.  Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.

Authors:  Mark Beswick; Annette Pachnio; Sarah N Lauder; Clive Sweet; Paul A Moss
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

10.  Altered regulation of CXCR4 expression during aging contributes to increased CXCL12-dependent chemotactic migration of CD4(+) T cells.

Authors:  Stefania Cané; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.